Navigation Links
Genes determine the capacity to fight HIV in early stages

ed as closely as possible in organ transplants, with perfect matches only possible between identical twins. Some studies have found that HIV patients with particular versions of HLA may be better able to control viral levels, but the diversity of HLA molecules – each person may have up to six different varieties of Class I proteins – has made investigating the role of HLA type in HIV infection challenging.

The current study was designed to determine the contribution of both HLA Class I and the particular viral fragments displayed on those molecules to the activation of HIV-specific CD8 cells. The researchers analyzed blood samples from more than 100 people recently infected with HIV, first determining their specific HLA types by DNA analysis. Then they focused on 173 HIV protein fragments known to bind to those HLA types to see if particular peptides were more powerful in activating the HIV-specific CD8 response. The researchers found that, for many varieties of HLA, only a few HIV protein fragments were responsible for the activation of CD8 T cells early in infection. In addition, the same HLA types that had been previously identified in people who stay healthy for a longer period of time after initial infection were associated with a more powerful early-stage HIV-specific CD8 activity. .

"While we can't say this for sure right now, it is looking like both the HLA Class I molecule and the specific viral sequences being displayed contribute to the strength of immune response against primary HIV infection," says Altfeld. "In addition, the combination of Class I molecules that an individual expresses, something that is genetically determined, seems to have a significant impact on the specificity and strength of that response. .

"Identifying the HIV epitopes [viral fragments] that are particularly good at priming an early T cell response may be important to vaccine design, and the impact of an individual's genetic HLA Class I backg
'"/>




Page: 1 2 3

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Genes for lung disease
3. Genesis of SUPAC
4. Genes for Vision discovered
5. Genes Found To Help Leukemia Treatment
6. Cardiac Valve Disease Linked To Genes
7. Genes Linked To Cigarette Addiction
8. Genes from saliva may predict oral and breast cancer
9. Genes More Important Than Exercise for Bad Cholesterol
10. Genes responsible for social behavior of us
11. Genes to Extend Longevity Discovered

Post Your Comments:
(Date:11/7/2009)... Nov. 7 Karen Ignagni, ...ans (AHIP), released the following statement today...s strongly support comprehensive health care refor...roposing a complete overhaul of how health insuran...ranteed coverage, elimination of pre-existing cond...
(Date:11/7/2009)...v. 7, The American Medi...min Rush Award for Citizenship and Community Servi...m Chicago, IL. The award recognizes physicians who...l of duty to make an outstanding public service co...eived the award today during the opening session o...
(Date:11/7/2009)...T. Coleman (CT), David A. Cook (GA), Louis J. Good...A) Honored ,, CHICAGO, Nov. 7 /PRNewswire-USNe...today presented five medical society executive lea...butions to the goals and ideals of the medical pro...mi-annual policy making meeting in Houston. ,,...
(Date:11/7/2009)...v. 7 Members of the AMA...mergency resolution rescinding the AMA,s support o...at they are responsible to their PATIENTS, not the...ctor of Policy for the Association of American Phy...alition of other medical groups. ,, "If the AM...
(Date:11/7/2009)...aithful Catholics have a responsibility to vigorou...he status quo." ,, WASHINGTON, Nov. 7 /PRNe...ent Judie Brown released the following statement o...t Speaker Nancy Pelosi,s Affordable Health Care fo...reserving the status quo for abortion is voted upo...
Breaking Medicine News(10 mins):Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
...ember Tom Torlakson Introduces AB 89 , , SACRAMEN...day, Lung Cancer Alliance-California (LCA-CA), hai...th District) for his continued leadership in intro...ing considered in the California Legislature. , ...
...bad cholesterol more effectively than Zocor , ...early a year of review, U.S. health officials said... the controversial cholesterol-lowering drug Vytor...atients taking the drug Zocor. , But, the agency r...
...sition in 2009 Continues Growth Trend , , NORTH H...any, Inc. (Nasdaq: IPCM ), a leading national ho...ced today that it has acquired the hospitalist pra...here IPC has established a significant presence. ...
...n assessing traditional risk factors, experts say ...wo molecular signs -- or "biomarkers" -- of inflam...to assess a person,s risk of stroke, new research ...ist at the Methodist DeBakey Heart & Vascular ...
...gated guidewire provides minimally-invasive treatm...as, Jan. 8 The Heart Hospital of Austin is the ...axis RF PowerAssert(TM) Magnetic Guidewire to succ...diologist, Frank Zidar, M.D. used the new device o...
... The physicians of Northern Lake Medical,Ltd., a ...rn Illinois,communities, announced today that they...o: http://www.newscom.com/cgi-bin/prnh/20090108/A.... , "The Northern Lake Medical physicians have...
Other Medicine News:Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3Health News:Heart Hospital of Austin First in World to Use New Device for Blocked Arteries 2Health News:Northern Lake Medical to Join Aurora Health Care 2Health News:Northern Lake Medical to Join Aurora Health Care 3
(Date:11/6/2009)...TICK, Mass., Nov. 6 Bost...unced that it has reached an agreement in principl...d to product advisories issued by its Guidant subs...ales occurred prior to Boston Scientific,s 2006 ac...previously disclosed an investigation by the U.S. ...
(Date:11/6/2009)...N DIEGO, Nov. 6 Ardea Bi...company focused on the development of small-molecu...and human immunodeficiency virus (HIV), today repo...for the third quarter and nine months ended Septem...om/cgi-bin/prnh/20091104/ARDEALOGO ) ,, "Since ...
(Date:11/6/2009)...LANTA, Nov. 6 GeoVax La..."the Company"), an Atlanta-based, biopharmaceutica...aused by HIV-1 (Human Immunodeficiency Virus) and ... quarter 2009 financial results and provided an op...sident and Chief Executive Officer commented, "We ...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Alcon Commences Phase 2 Clinical Trial of NovaBays NVC 422 for Viral Conjunctivitis 4680 1Alcon Commences Phase 2 Clinical Trial of NovaBays NVC 422 for Viral Conjunctivitis 4680 2Alcon Commences Phase 2 Clinical Trial of NovaBays NVC 422 for Viral Conjunctivitis 4680 3Alcon Commences Phase 2 Clinical Trial of NovaBays NVC 422 for Viral Conjunctivitis 4680 4Working Out in the Garden 50717 1On Memory Older Americans Outsmart the English 50713 1On Memory Older Americans Outsmart the English 50713 2
Fixed Core Straight Safety Wire Guides - Standard (stainless steel)
Mitty-Pollack Needle Set - Standard
Light Guide Cables - 3.5mm
High Transmission Autoclavable Fiberoptic Light Guide, with 45 angled instrument fitting, snap-on
Medicine Products: